Healthcare | July 23, 2025
Fortis and Gleneagles India deepen collaboration to drive growth
Combined strength of two brands across 11 states to elevate patient care delivery and access to doctors
Combined strength of two brands across 11 states to elevate patient care delivery and access to doctors
Reported EBITDA up by 19% year-on-year with reported EBITDA margin at 25%
Aims to support healthcare practitioners with evidence-based cough categorization tools that enable choosing the right molecules for effective & targeted relief from cough
Plant-based chemistries have an outsized role to play for the HPC sector by meeting demand for good, gentle, and green products
Enables additional US manufacturing capacity to serve increased demand for pharma/biotech customers
The transaction, approved by both companies' boards of directors, is expected to close by the end of the first quarter of 2026
The agreement includes plans for distribution, technology transfer, local manufacturing, new pharmaceutical product development
New platform powered by Opentrons expands lab automation to accelerate scientific discovery
LEQSELVI now available for prescription in U.S. nationwide, offering a new option for eligible patients
Havix is a US based company engaged in the business of developing, manufacturing and supplying of various finished formulations
Subscribe To Our Newsletter & Stay Updated
